FindTrial
Sign In

Serum levels of relaxin family-related peptides (RLN) as a diagnostic predictor of adolescent idiopathic scoliosis (AIS) for clinical evaluation and screening

Serum levels of relaxin family-related peptides (RLN) as a diagnostic predictor of adolescent idiopathic scoliosis (AIS) for clinical evaluation and screening

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035435
Enrollment
Unknown
Registered
2020-08-11
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adolescent idiopathic scoliosis

Interventions

AIS:Nil
No AIS:Nil

Sponsors

Department of Orthopedics, the First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Aged 12-18 years old female, diagnosed with juvenile idiopathic scoliosis LENKE1A, RISSER sign 0-IV degree.

Exclusion criteria

Exclusion criteria: Diagnosed with non-idiopathic scoliosis such as neuromuscular spinal deformity, congenital spinal deformity, male, over 18 years old or under 12 years old, RISSER sign greater than IV degree

Design outcomes

Primary

MeasureTime frame
RLN1 serum level;RLN2 serum level;RLN3 serum level;Estrogen level;—

Countries

China

Contacts

Public ContactYang Zongde

Department of Orthopedics, the First Affiliated Hospital of Naval Medical University

yangzongde@139.com+86 18721958758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026